Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery SOX9
Path
Created with Sketch.
Go to SOX9 Normal Tissue Gallery
Go back to Product Page
Colon – Colorectal adenocarcinoma with moderate to strong SOX9 immunostaining of tumor cells
Colon – Colorectal adenocarcinoma with moderate to strong SOX9 immunostaining of tumor cells
Esophagus – Adenocarcinoma with strong SOX9 staining of most tumor cells
Esophagus – Adenocarcinoma with strong SOX9 staining of most tumor cells
Esophagus – SOX9 negative adenocarcinoma
Esophagus – SOX9 negative adenocarcinoma
Esophagus – Squamous cell carcinoma with strong SOX9 immunostaining of most tumor cells
Esophagus – Squamous cell carcinoma with strong SOX9 immunostaining of most tumor cells
Kidney – SOX9 negative clear cell carcinoma
Kidney – SOX9 negative clear cell carcinoma
Kidney – SOX9 negative oncocytoma
Kidney – SOX9 negative oncocytoma
Liver – Hepatocellular carcinoma with weak to moderate SOX9 immunostaining of most tumor cells
Liver – Hepatocellular carcinoma with weak to moderate SOX9 immunostaining of most tumor cells
Lymph node – SOX9 negative diffuse large B-cell lymphoma
Lymph node – SOX9 negative diffuse large B-cell lymphoma
Lymph node – Diffuse large B-cell lymphoma with moderate to strong SOX9 immunostaining of most tumor cells
Lymph node – Diffuse large B-cell lymphoma with moderate to strong SOX9 immunostaining of most tumor cells
Lymph node – Follicular B-cell lymphoma with weak to moderate SOX9 staining of a small fraction of cells
Lymph node – Follicular B-cell lymphoma with weak to moderate SOX9 staining of a small fraction of cells
Lymph node – SOX9 negative Hodgkin’s lymphoma
Lymph node – SOX9 negative Hodgkin’s lymphoma
Oral cavity – Squamous cell carcinoma with weak to moderate SOX9 staining of tumor cells
Oral cavity – Squamous cell carcinoma with weak to moderate SOX9 staining of tumor cells
Ovary – Endometroid carcinoma with moderate to strong SOX9 staining of tumor cells
Ovary – Endometroid carcinoma with moderate to strong SOX9 staining of tumor cells
Ovary – Malignant mixed Mullerian tumor with moderate to strong SOX9 immunostaining of tumor cells
Ovary – Malignant mixed Mullerian tumor with moderate to strong SOX9 immunostaining of tumor cells
Ovary – Serous high-grade carcinoma with moderate to strong SOX9 immunostaining of most tumor cells
Ovary – Serous high-grade carcinoma with moderate to strong SOX9 immunostaining of most tumor cells
Ovary – SOX9 negative clear cell carcinoma
Ovary – SOX9 negative clear cell carcinoma
Pancreas – Adenocarcinoma of the papilla Vaterii with moderate to strong SOX9 staining of tumor cells
Pancreas – Adenocarcinoma of the papilla Vaterii with moderate to strong SOX9 staining of tumor cells
Pancreas – Neuroendocrine tumor lacking SOX9 immunostaining in tumor cells
Pancreas – Neuroendocrine tumor lacking SOX9 immunostaining in tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with weak to moderate SOX9 staining of tumor cells
Prostate – Adenocarcinoma (Gleason 3+3=6) with weak to moderate SOX9 staining of tumor cells
Prostate – Small cell carcinoma with strong SOX9 positivity of tumor cells
Prostate – Small cell carcinoma with strong SOX9 positivity of tumor cells
Prostate – SOX9 negative adenocarcinoma (Gleason 3+3=6)
Prostate – SOX9 negative adenocarcinoma (Gleason 3+3=6)
Salivary gland – Basal cell adenoma with strong SOX9 staining of all tumor cells
Salivary gland – Basal cell adenoma with strong SOX9 staining of all tumor cells
Salivary gland – Warthin tumor with strong SOX9 staining of most epithelial tumor cells
Salivary gland – Warthin tumor with strong SOX9 staining of most epithelial tumor cells
Skin – Basal cell carcinoma with moderate to strong SOX9 immunostaining of neoplastic cells
Skin – Basal cell carcinoma with moderate to strong SOX9 immunostaining of neoplastic cells
Skin – Malignant melanoma with a moderate SOX9 positivity of most tumor cells
Skin – Malignant melanoma with a moderate SOX9 positivity of most tumor cells
Skin – Merkel cell carcinoma with SOX9 staining of variable intensity in most tumor cells
Skin – Merkel cell carcinoma with SOX9 staining of variable intensity in most tumor cells
Soft tissue – Leiomyosarcoma with weak to moderate SOX9 positivity of a fraction of tumor cells
Soft tissue – Leiomyosarcoma with weak to moderate SOX9 positivity of a fraction of tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with intense SOX9 immunostaining of tumor cells
Stomach – Gastric adenocarcinoma (diffuse type) with intense SOX9 immunostaining of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong SOX9 positivity of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong SOX9 positivity of tumor cells
Stomach – SOX9 negative gastrointestinal stromal tumor (GIST)
Stomach – SOX9 negative gastrointestinal stromal tumor (GIST)
Testis – Sertoli cell tumor with strong SOX9 staining of a small fraction of tumor cells
Testis – Sertoli cell tumor with strong SOX9 staining of a small fraction of tumor cells
Testis – SOX9 negative seminoma
Testis – SOX9 negative seminoma
Thyroid – SOX9 negative medullary carcinoma
Thyroid – SOX9 negative medullary carcinoma
Thyroid – SOX9 negative papillary carcinoma
Thyroid – SOX9 negative papillary carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with strong SOX9 immunostaining of most tumor cells
Urinary bladder – Muscle-invasive urothelial carcinoma with strong SOX9 immunostaining of most tumor cells
Urinary bladder – Small cell carcinoma with strong SOX9 immunostaining of all tumor cells
Urinary bladder – Small cell carcinoma with strong SOX9 immunostaining of all tumor cells
Uterus, cervix – Adenocarcinoma with strong SOX9 positivity of 100_ of tumor cells
Uterus, cervix – Adenocarcinoma with strong SOX9 positivity of 100_ of tumor cells
Uterus, cervix – SOX9 negative squamous cell carcinoma
Uterus, cervix – SOX9 negative squamous cell carcinoma